Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis

NCT02050646 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02050646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02050646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
August 27, 2013
Completion date
June 30, 2021
Enrollment
16 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune hepatitis